Get the latest Science News and Discoveries

Eradivir's EV25 therapeutic reduces advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies


None

Get the Android app

Or read this on ScienceDaily

Read more on:

Photo of current therapies

current therapies

Photo of viral loads

viral loads

Photo of Eradivir

Eradivir

Related news:

News photo

Eradivir’s EV25 therapeutic proven to reduce - EurekAlert

News photo

Preclinical studies suggest a drug-free nasal spray could ward off respiratory infections - EurekAlert

News photo

Two-pronged attack strategy boosts immunotherapy in preclinical studies - EurekAlert